(Q34546898)

2 August 2017

title

Kidney after nonrenal transplantation-the impact of alemtuzumab induction (English)

1 reference

2 August 2017

17

Thomas E Starzl

1 reference

2 August 2017

1

Ron Shapiro

1 reference

2 August 2017

2

Amit Basu

1 reference

2 August 2017

15

Kareem Abu-Elmagd

1 reference

2 August 2017

9

Jerry McCauley

1 reference

2 August 2017

7

Parmjeet S Randhawa

1 reference

2 August 2017

Henkie P Tan

3

1 reference

2 August 2017

Claire Morgan

4

1 reference

2 August 2017

Vivek Sharma

5

1 reference

2 August 2017

Deanna Blisard

6

1 reference

2 August 2017

Igor Dvorchik

8

1 reference

2 August 2017

Demetrius Ellis

10

1 reference

2 August 2017

J Wallis Marsh

11

1 reference

2 August 2017

Steven Webber

12

1 reference

2 August 2017

Geoffrey Kurland

13

1 reference

2 August 2017

Kenneth R McCurry

14

1 reference

2 August 2017

George Mazariegos

16

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

2 August 2017

1 reference

2 August 2017

volume

88

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

799-802

1 reference

Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Chronic renal failure after transplantation of a nonrenal organ

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

A personal history of the CAMPATH-1H antibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032633

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19920779

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/TP.0B013E3181B4AAF5

1 reference

2 August 2017

1 reference

2 August 2017

1 reference